Primary cardiac sarcoma: reports of two cases and a review of current literature by Mohan P Devbhandari et al.
BioMed CentralJournal of Cardiothoracic Surgery
ssOpen AcceReview
Primary cardiac sarcoma: reports of two cases and a review of 
current literature
Mohan P Devbhandari*, Shaista Meraj, Mark T Jones, Isaac Kadir and 
Ben Bridgewater
Address: Department of Cardiothoracic Surgery, Wythenshawe Hospital,Manchester,UK. M23 9LT
Email: Mohan P Devbhandari* - mohandev@hotmail.com; Shaista Meraj - shaista.meraj@smuht.nwest.nhs.uk; 
Mark T Jones - Mark.Jones@smuht.nwest.nhs.uk; Isaac Kadir - Isaac.Kadir@smuht.nwest.nhs.uk; 
Ben Bridgewater - Ben.Bridgewater@smuht.nwest.nhs.uk
* Corresponding author    
Abstract
Primary cardiac sarcomas are rare tumors with an unfavourable prognosis. Complete surgical
resection is currently the only mode of therapy proven to show any benefit. We report the cases
of two patients presenting with features of obstruction and embolism and a presumed diagnosis of
left atrial myxoma. At operation they were unexpectedly found to have large tumours raising
strong suspicions of malignancy. Due to the extensive involvement of intracardiac structures with
little possibility of reconstruction together with poor general condition of the patient, debulking
was deemed to be the only viable option. Subsequent histology confirmed the diagnosis of sarcoma
in both patients. Surgery produced immediate and effective symptom relief. The first patient died
four months after the operation and second patient is still alive at 12 months after her operation.
A brief review of literature on cardiac sarcoma is presented.
Background
Primary cardiac tumours are rare [1] with an incidence of
0.0017 to 0.019%. Seventy-five percent of them are
benign mostly myxomas and 25% are malignant predom-
inantly consisting of sarcomas [2,3]. While tumours of
vascular origin such as angiosarcoma are the commonest
sarcoma of the heart, tumors of all cell lines including
bony, neurogenic and soft tissue sarcomas have been
reported to arise de novo from the heart. It is important to
note that metastatic tumours in the heart are 20 to 30
times commoner than primary tumours [4]. Because of
non-specificity of symptoms and rarity of these tumours
they are often difficult to diagnose preoperatively and are
missed occasionally. The advent of modern investigative
tools including transesophageal echocardiogram, CT scan
and cardiac MRI increases the likelihood of preoperative
diagnosis. The majority are presumed to be benign
myxoma and the suspicion of sarcomas is only made at
the time of operation due to its invasive nature. Due to
rarity of these tumours and lack of large representative
case series, there is no uniform approach to treating these
patients, and the benefits of adjuvant therapy are unclear
[5]. We report on two cases of cardiac sarcoma treated in
our hospital with a brief review of current literature.
Case presentations
Case 1
An 84-year-old lady presented with 6 weeks history of
acute onset dyspnoea, lethargy and repeated haemoptysis.
She had a previous history of chronic atrial fibrillation,
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thrombosis. Clinical examination, blood tests and chest x
ray were unremarkable. Her echocardiogram showed a
large 4.2 × 5 cm echogenic mass in left atrium with mod-
erate mitral regurgitation. Coronary angiography showed
single vessel disease affecting the right coronary artery. A
CT scan of the chest ruled out pulmonary embolism. A
provisional diagnosis of left atrial myxoma or a thrombus
was made and patient taken to theatre for an urgent sur-
gery. The entire left atrial cavity was found to be filled with
jelly like mass, which was diffusely infiltrating the left
atrial wall. A curative resection was deemed impossible
and debulking was performed. The patient made an une-
ventful recovery with significant improvement of symp-
toms. Histology confirmed the tumour to be
undifferentiated pleomorphic sarcoma [figure 1]. Due to
her advanced age and frailty she was not considered to be
a suitable candidate for further treatment. Four months
later she developed a metastatic pathological fracture of
left femur requiring internal fixation. She developed
severe bronchopneumonia postoperatively and suc-
cumbed to it. Her relatives declined post mortem exami-
nation.
Case 2
A 37-year-old lady presented with 3 months history of
right-sided pleuritic chest pain, high fever, night sweats
and dry cough. She was extremely breathless with poor
oxygenation and her blood tests showed presence of anae-
mia. Her chest x ray showed an ill-defined shadow on the
right side of her chest. Despite treatment with broad-spec-
trum antibiotic for presumed chest infection her symp-
toms deteriorated. A contrast CT revealed cardiomegaly
and a filling defect in the left atrium extending through
the left ventricle. There was patchy non-specific shadow-
ing in the right upper and middle lobes and a pleural effu-
sion. A trans-thoracic echocardiogram confirmed a large
4.5 × 5 cm left atrial mass filling the entire left atrium and
prolapsing into the left ventricle through the mitral valve.
She continued to deteriorate and was extremely breathless
at surgical presentation. She was taken to theatre with pre-
sumptive diagnosis of atrial myxoma. At surgery a large
tumour was found arising from the left atrial side of the
atrial septum at the confluence of the right superior pul-
monary vein and superior vena cava. It was gelatinous in
consistency and had a wide base. It was partly extending
into the right superior pulmonary vein. The tumour was
resected as completely as possible and the left atrium was
reconstructed with a patch of pericardium. Postopera-
tively she made an uneventful recovery and was dis-
charged home after a week. Definitive histology
confirmed the tumour to be a myxoid sarcoma [Figure 2].
She underwent radiotherapy locally to chest but she
declined chemotherapy. She is still alive twelve months
after the operation. Her surveillance CT scan has not
shown any evidence of local or distant recurrence.
Discussion
Cardiac sarcomas are uncommon tumours. Approxi-
mately 25% of primary cardiac tumours are malignant
and of these about 75% are sarcomas. In a large reported
series angiosarcoma was the commonest (37%) followed
by malignant fibrous histiocytoma (MFH) 24%, leiomy-
osarcoma 9%, rhabdomyosarcoma 7%, unclassified 7%,
others 16% [5]. Angiosarcoma tends to be commoner in
the right atrium and ventricle and MFH is commoner on
the left side. These highly malignant tumours rapidly infil-
trate all layers of the heart and metastasise widely. Hence
up to 80% of patients have evidence of metastasis at the
time of presentation [4].
The mean age of presentation is around 40 years [6] with
no sex predilection. Rarely it can present in infancy and
childhood [7]. Patients present after variable periods of
symptoms which are often non-specific, ranging from few
weeks to several months and almost all are symptomatic
at presentation. The symptoms depend on the location
and the extent of tumour. They manifest by one of the
four mechanisms namely: obstruction to blood flow and
valvular function, local invasion causing arrhythmia or
pericardial effusion, embolism or systemic symptoms of
dyspnoea, fever malaise and weight loss [8]. Dyspnea is
the commonest symptom 60%, followed by chest pain
28%, congestive cardiac failure 28%, palpitations 24%,
fever 14%, myalgia 10%, embolism 5% and constitu-
tional symptoms of weakness, fever, anaemia [5].
Echocardiography by transthoracic or preferably trans-
esophageal route is a convenient, rapid and inexpensive
tool to identify intracardiac masses. A number of features
have been reported that differentiate sarcomas from
benign myxoma [9]. They are: 1) non-septal origin of
mass, 2) extension into the pulmonary vein, 3) multiple
masses, 4) a broad attachment on the left atrial wall, and
5) semisolid consistency. As illustrated by our cases and
others [9] the picture is not easy to interpret and true diag-
nosis is only made as a unexpected finding at the operat-
ing table. Even if the diagnosis had been confirmed
beforehand in our cases this still would not have changed
our management, as surgery would still have been the best
means of symptom relief.
The CT and MRI scans of chest and abdomen are comple-
mentary to echocardiography. They have the advantage of
showing the extracardiac extent of tumour and presence of
metastases in addition to the anatomical details of the
lesion. CT scan shows myocardial infiltration, compres-
sion of cardiac chambers along with pericardial and great
vessel involvement. MRI is useful to assess tumour vol-Page 2 of 5
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to therapy. Chest x ray may show cardiomegaly, infiltrates
suggestive of congestive cardiac failure, pleural effusion,
lung nodules, cardiac mass or left hemidiaphragm paraly-
sis. Electrocardiogram is usually non-diagnostic being
normal or may show non-specific changes such as con-
duction block right ventricular hypertrophy, atrial fibrilla-
tion, paroxysmal atrial tachycardia etc. A thorough search
is mandatory for signs of metastasis, as up to 80% may
have systemic metastasis at diagnosis, most commonly in
the lung. Cytology of fine needle aspiration and pericar-
dial biopsies for pericardial infiltration have not shown
very accurate results. Transvenous endomyocardial biopsy
is helpful to yield a histological confirmation before oper-
ation [10].
The role of chemotherapy or radiotherapy in the treat-
ment of primary cardiac sarcoma has not proven to be
beneficial and complete surgical excision is the only mode
of therapy that has been shown to prolong survival [5].
Complete resection is possible in up to55% of cases where
involvement is limited to atrial septum, small part of ven-
tricle or valve. Additionally surgery also has a role in pal-
liative resections for relief of symptoms, biopsy to confirm
diagnosis or repeated resections. The operative mortality
for surgical resection of cardiac sarcoma is high albeit
acceptable at about 8.3% [5]. If malignancy is suspected
or confirmed and the lesion appears anatomically resecta-
ble, with no evidence of spread, a complete resection
should be considered [2]. Though the initial results of sur-
gery are encouraging their long-term survival remains
poor mostly due to local or systemic recurrence. Never the
less surgery has been shown to prolong the survival and
improve the quality of life.
The role of adjuvant chemotherapy remains undefined
though there are some reports of adriamycin [5] and dox-
orubicin [7] showing some improvement in survival. Poor
tolerance of radiation by the heart has limited the use of
radiotherapy. Its role remains unproven though it has
been used for treatment of positive margins after resec-
tions, palliation of aggressive localized disease and local
CT scan shows a large filling defect (black arrow) in the left atriumFigure 1
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ler have reviewed reports of 21 patients who underwent
transplantation for inoperable cardiac malignancy with
overall mean survival or 12 months [11]. The concern
about this mode of treatment is the possibility that immu-
nosuppression may stimulate further tumour growth or
recurrence and new neoplasia. In the current era of
increasingly severe scarcity of donor organs this is unlikely
to be a popular choice. This mode of treatment is advisa-
ble only for selected cases of widely resected non-angiosa-
rcoma tumours with no obvious distant disease. Recently
Reardon and colleagues have described successful tumour
resection by explantation of the heart, complete tumour
excision and then re-implantation in native position lead-
ing to long-term survival [12] in a small series of patients.
This is difficult to reproduce in daily practice by non-
transplant cardiac surgery centres. Where clinical suspi-
cion is present preoperatively, these patients may be better
served by referral to a designated national centre with
expertise and interest in treatment of cardiac malignan-
cies.
The completeness of surgical resection depends on the
location of the tumour, extent of involvement of the myo-
cardium and histology. In a reported series patients with
complete resection were found to have median survival of
24 months compared to overall median survival of 10
months in all treated patients [5]. Overall actuarial sur-
vival was 14% at 24 months with median survival of 11
months. Prolonged survival of 10 years after a complete
excision of left atrium rhabdomyosarcoma has been
reported previously. Factors associated with increased sur-
vival after a resection of cardiac sarcoma are a left-sided
location, mitotic rate less than 10 per high power field
and absence of necrosis on histology [6]. Predictors of
long-term mortality include NYHA class III and IV symp-
toms. Most of the patients ultimately die of metastasis or
heart failure.
Histology showing appearance of sarcomaFigure 2
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High index of suspicion is required to achieve timely pre-
operative diagnosis of these patients. Wide surgical exci-
sion remains the only proven therapy which improves the
symptoms and offers the potential for long term survival
in selected patients. Role of adjuvant treatment still
remains undefined.
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